|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.06 USD | -3.87% |
|
+5.72% | -4.55% |
| Market Cap | 3.26B 2.85B 2.63B 2.44B 4.63B 309B 4.7B 31.53B 12.26B 153B 12.24B 11.98B 528B | P/E 2026 * |
241x | P/E 2027 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3B 2.62B 2.42B 2.24B 4.25B 284B 4.32B 28.98B 11.27B 140B 11.25B 11.01B 485B | EV / Sales 2026 * |
6.03x | EV / Sales 2027 * | 4.15x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | +6.33% | ||
| 1 week | +5.72% | ||
| Current month | +5.72% | ||
| 1 month | +28.69% | ||
| 3 months | +19.12% | ||
| 6 months | -6.29% | ||
| Current year | -4.55% |
| 1 week | 25.25 |  | 27.8 |
| 1 month | 21 | | 28.38 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.34 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 2017-03-31 |
| Corporate Officer/Principal | 71 | 2025-12-02 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 2019-11-30 |
Todd Watanabe
BRD | Director/Board Member | 58 | 2015-12-31 |
Howard Welgus
BRD | Director/Board Member | 74 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Director | -635 | 0.0005% | ||
| 06-14 | Sell | Director | -4,946 | 0.0040% | ||
| 06-04 | Free | Director | 22,445 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | +5.72% | +107.02% | +199.68% | 3.26B | |
| +1.16% | +8.59% | +25.83% | -2.21% | 66.11B | |
| -0.24% | -3.13% | +49.38% | +223.97% | 55.3B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 42.44B | |
| -0.21% | +7.44% | -48.93% | -54.50% | 41.28B | |
| -3.42% | +14.22% | +167.51% | -32.71% | 32.46B | |
| -1.60% | -4.47% | +58.61% | -24.96% | 30.78B | |
| -0.97% | +4.02% | +75.29% | +89.98% | 23.1B | |
| -3.65% | +8.93% | +1.16% | +184.50% | 20.06B | |
| -0.04% | +3.85% | +67.76% | +135.89% | 17.19B | |
| Average | +0.52% | +4.54% | +54.58% | +76.18% | 33.2B | |
| Weighted average by Cap. | +0.48% | +4.09% | +44.36% | +56.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 435M 401M 372M 705M 47.18B 717M 4.81B 1.87B 23.28B 1.87B 1.83B 80.48B | 646M 565M 521M 483M 916M 61.29B 931M 6.25B 2.43B 30.25B 2.42B 2.37B 105B |
| Net income | 15.18M 13.28M 12.24M 11.34M 21.54M 1.44B 21.88M 147M 57.07M 711M 56.98M 55.74M 2.46B | 134M 117M 108M 100M 191M 12.74B 194M 1.3B 505M 6.29B 504M 493M 21.73B |
| Net Debt | -265M -232M -213M -198M -375M -25.11B -381M -2.56B -995M -12.39B -993M -972M -42.83B | -580M -507M -468M -433M -823M -55.03B -836M -5.61B -2.18B -27.16B -2.18B -2.13B -93.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$27.74 | +6.39% | 2,060,285 |
| 26-07-06 | US$26.07 | +1.01% | 1,290,402 |
| 26-07-02 | US$25.81 | -0.12% | 1,198,181 |
| 26-07-01 | US$25.84 | -1.45% | 937,771 |
| 26-06-30 | US$26.22 | -2.02% | 1,354,101 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
